Stock Update (NYSE:CVS): CVS Health Research Institute Study Shows that Home Infusion Care Improves Patient Outcomes and Quality of Life While Reducing Overall Costs

[PR Newswire] – WOONSOCKET, R.I., May 4, 2016 /PRNewswire/ — A new study by the CVS Health Research Institute found that home infusion care is safe, clinically effective and improves quality of life while reducing health … Read more on this. CVS Health Corporation (CVS) , valued at $114.24B, ended trading yesterday at $103.92. Looking at today’s trading action, the company’s one day range from $102.93 to $103.90 with its 52-week range being $81.37 to $113.65. CVS (CVS) shares are currently priced at 17.83x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 13.47x earnings multiple for the same period. And for income investors, the company pays shareholders $1.70 per share annually in dividends, yielding 1.69%. Consensus earnings for the current quarter by the 23 sell-side analysts covering the stock is an estimate of $1.33 per share, which would be $0.11 better than the year-ago quarter and a $0.02 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $5.83 would be a $0.67 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $44.11 Billion. If reported, that would be a 18.67% increase over the year-ago quarter. More recently, Atlantic Equities Initiated CVS at Overweight (Feb 3, 2016). Previously, Robert W. Baird Initiated CVS at to Outperform. Investors should keep in mind is that the average price target is $113.18, which is 8.91% above where the stock opened this morning. See more in (NYSE:CVS) Similar Articles: Stock Update (NYSE:CVS): CVS Health Receives URAC Accreditation for Specialty Pharmacy Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Receives URAC Accreditation for Mail Service Pharmacy Stock Update (NYSE:CVS): CVS Health Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect™ Pilot